column
Editorial of Special Column on A New Era of Nanobiomaterial-based Drug Delivery
Haijun Yu, Zhiyong Qian,
2022, 12(9):3453-3455. DOI:10.1016/j.apsb.2022.08.002
Abstract
Mucosal vaccine delivery: A focus on the breakthrough of specific barriers
Mengwen Huang, Miaomiao Zhang, Hongbin Zhu, Xiaojiao Du, Jun Wang,
2022, 12(9):3456-3474. DOI:10.1016/j.apsb.2022.07.002
Abstract
Combination therapy using microwave ablation and d-mannose-chelated iron oxide nanoparticles inhibits hepatocellular carcinoma progression
Rui Cui, Luo Wang, Dongyun Zhang, Kun Zhang, Jianping Dou, Linan Dong, Yixuan Zhang, Jiapeng Wu, Longfei Tan, Jie Yu, Ping Liang,
2022, 12(9):3475-3485. DOI:10.1016/j.apsb.2022.05.026
Abstract
Dual-targeting prodrug nanotheranostics for NIR-Ⅱ fluorescence imaging-guided photo-immunotherapy of glioblastoma
Fenglin Li, Yi Lai, Jiayi Ye, Madiha Saeed, Yijing Dang, Zhifeng Zou, Fangmin Chen, Wen Zhang, Zhiai Xu,
2022, 12(9):3486-3497. DOI:10.1016/j.apsb.2022.05.016
Abstract
Multi-functional vesicles improve Helicobacter pylori eradication by a comprehensive strategy based on complex pathological microenvironment
Xiaonan Chen, Yiqing Zou, Shuqi Zhang, Pengchao Fang, Shuxuan Li, Pengyu Li, Yingying Sun, Gang Yuan, Haiyan Hu,
2022, 12(9):3498-3512. DOI:10.1016/j.apsb.2022.05.014
Abstract
Critical involvement of lysyl oxidase in seizure-induced neuronal damage through ERK-Alox5-dependent ferroptosis and its therapeutic implications
Xiaoyuan Mao, Xuan Wang, Mingzhu Jin, Qin Li, Jining Jia, Menghuan Li, Honghao Zhou, Zhaoqian Liu, Weilin Jin, Yanli Zhao, Zhong Luo,
2022, 12(9):3513-3528. DOI:10.1016/j.apsb.2022.04.017
Abstract
Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD: A promising drug Potentilla discolor Bunge
Longshan Ji, Qian Li, Yong He, Xin Zhang, Zhenhua Zhou, Yating Gao, Miao Fang, Zhuo Yu, Robim M. Rodrigues, Yueqiu Gao, Man Li,
2022, 12(9):3529-3547. DOI:10.1016/j.apsb.2022.05.001
Abstract
Molecular glues modulate protein functions by inducing protein aggregation: A promising therapeutic strategy of small molecules for disease treatment
Hongyu Wu, Hong Yao, Chen He, Yilin Jia, Zheying Zhu, Shengtao Xu, Dahong Li, Jinyi Xu,
2022, 12(9):3548-3566. DOI:10.1016/j.apsb.2022.03.019
Abstract
Non-apoptotic cell death-based cancer therapy: Molecular mechanism, pharmacological modulators, and nanomedicine
Xuan Wang, Peng Hua, Chengwei He, Meiwan Chen,
2022, 12(9):3567-3593. DOI:10.1016/j.apsb.2022.03.020
Abstract
An integrative approach of digital image analysis and transcriptome profiling to explore potential predictive biomarkers for TGFβ blockade therapy
Robert Pomponio, Qi Tang, Anthony Mei, Anne Caron, Bema Coulibaly, Joachim Theilhaber, Maximilian Rogers-Grazado, Michele Sanicola-Nadel, Souad Naimi, Reza Olfati-Saber, Cecile Combeau, Jack Pollard, Tun Tun Lin, Rui Wang,
2022, 12(9):3594-3601. DOI:10.1016/j.apsb.2022.03.013
Abstract
LncRNA DACH1 protects against pulmonary fibrosis by binding to SRSF1 to suppress CTNNB1 accumulation
Jian Sun, Tongzhu Jin, Zhihui Niu, Jiayu Guo, Yingying Guo, Ruoxuan Yang, Qianqian Wang, Huiying Gao, Yuhan Zhang, Tianyu Li, Wenxin He, Zhixin Li, Wenchao Ma, Wei Su, Liangliang Li, Xingxing Fan, Hongli Shan, Haihai Liang,
2022, 12(9):3602-3617. DOI:10.1016/j.apsb.2022.04.006
Abstract
Inhibition of ASCT2 induces hepatic stellate cell senescence with modified proinflammatory secretome through an IL-1α/NF-κB feedback pathway to inhibit liver fibrosis
Feixia Wang, Zhanghao Li, Li Chen, Ting Yang, Baoyu Liang, Zili Zhang, Jiangjuan Shao, Xuefen Xu, Guoping Yin, Shijun Wang, Hai Ding, Feng Zhang, Shizhong Zheng,
2022, 12(9):3618-3638. DOI:10.1016/j.apsb.2022.03.014
Abstract
FOXO3 mutation predicting gefitinib-induced hepatotoxicity in NSCLC patients through regulation of autophagy
Shaoxing Guan, Xi Chen, Youhao Chen, Guohui Wan, Qibiao Su, Heng Liang, Yunpeng Yang, Wenfeng Fang, Yan Huang, Hongyun Zhao, Wei Zhuang, Shu Liu, Fei Wang, Wei Feng, Xiaoxu Zhang, Min Huang, Xueding Wang, Li Zhang,
2022, 12(9):3639-3649. DOI:10.1016/j.apsb.2022.02.006
Abstract
Targeting a novel inducible GPX4 alternative isoform to alleviate ferroptosis and treat metabolic-associated fatty liver disease
Jie Tong, Dongjie Li, Hongbo Meng, Diyang Sun, Xiuting Lan, Min Ni, Jiawei Ma, Feiyan Zeng, Sijia Sun, Jiangtao Fu, Guoqiang Li, Qingxin Ji, Guoyan Zhang, Qirui Shen, Yuanyuan Wang, Jiahui Zhu, Yi Zhao, Xujie Wang, Yi Liu, Shenxi Ouyang, Chunquan Sheng, Fuming Shen, Pei Wang,
2022, 12(9):3650-3666. DOI:10.1016/j.apsb.2022.02.003
Abstract
Small molecule SMU-CX24 targeting toll-like receptor 3 counteracts inflammation: A novel approach to atherosclerosis therapy
Xiaohong Cen, Baoqu Wang, Yuqing Liang, Yanlin Chen, Yu Xiao, Shaohua Du, Kutty Selva Nandakumar, Hang Yin, Shuwen Liu, Kui Cheng,
2022, 12(9):3667-3681. DOI:10.1016/j.apsb.2022.06.001
Abstract
In situ synthesis and unidirectional insertion of membrane proteins in liposome-immobilized silica stationary phase for rapid preparation of microaffinity chromatography
Yanqiu Gu, Rong Wang, Panpan Chen, Shengnan Li, Xinyi Chai, Chun Chen, Yue Liu, Yan Cao, Diya Lv, Zhanying Hong, Zhenyu Zhu, Yifeng Chai, Yongfang Yuan, Xiaofei Chen,
2022, 12(9):3682-3693. DOI:10.1016/j.apsb.2022.04.010
Abstract
Combining immune checkpoint blockade with ATP-based immunogenic cell death amplifier for cancer chemo-immunotherapy
Jiulong Zhang, Xiaoyan Sun, Xiufeng Zhao, Chunrong Yang, Menghao Shi, Benzhuo Zhang, Haiyang Hu, Mingxi Qiao, Dawei Chen, Xiuli Zhao,
2022, 12(9):3694-3709. DOI:10.1016/j.apsb.2022.05.008
Abstract
Cooperative coordination-mediated multi-component self-assembly of “all-in-one” nanospike theranostic nano-platform for MRI-guided synergistic therapy against breast cancer
Xiaojie Chen, Xudong Fan, Yue Zhang, Yinghui Wei, Hangsheng Zheng, Dandan Bao, Hengwu Xu, Ji-Gang Piao, Fanzhu Li, Hongyue Zheng,
2022, 12(9):3710-3725. DOI:10.1016/j.apsb.2022.02.027
Abstract
Lenvatinib- and vadimezan-loaded synthetic high-density lipoprotein for combinational immunochemotherapy of metastatic triple-negative breast cancer
Chao Zheng, Wen Zhang, Jinming Wang, Yihui Zhai, Fengqin Xiong, Ying Cai, Xiang Gong, Binyu Zhu, Helen He Zhu, Hao Wang, Yaping Li, Pengcheng Zhang,
2022, 12(9):3726-3738. DOI:10.1016/j.apsb.2022.02.021
Abstract
Rapid screening of SARS-CoV-2 inhibitors via ratiometric fluorescence of RBD–ACE2 complexes in living cells by competitive binding
Lu Miao, Wei Zhou, Chunyu Yan, Yuebin Zhang, Qinglong Qiao, Xuelian Zhou, Yingzhu Chen, Guangying Wang, Zhendong Guo, Jun Liu, Hailong Piao, Xia Pan, Mengxue Yan, Weijie Zhao, Guohui Li, Yueqing Li, Zhaochao Xu,
2022, 12(9):3739-3742. DOI:10.1016/j.apsb.2022.05.033
Abstract

Copyright © 2014 Editorial Office of Acta Pharmaceutica Sinica